News
- Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
- Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
- Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene / Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
Visit the News Archives
Patient Content Spotlight: A.D.A.M. Health Risk Assessments
A.D.A.M. Health Risk Assessments include a series of 16 comprehensive tools with targeted recommendations based on a user’s specific health risks and health profile.
Wyeth Reports Financial Results for the 2008 Third Quarter and First Nine Months
Wyeth will announce 2008 Third Quarter and First Nine Months Financial Results on Wednesday, October 22, 2008 and will hold a one-hour conference call to discuss earnings.
Learn and Confirm: A New Paradigm for Clinical Development at Wyeth
Wyeth has launched a transforming initiative to develop the best clinical development model for the 21st
century.
Features
Patient Assistance Program
Wyeth can offer help if you or someone you know does not have insurance coverage and other financial resources to pay for a prescribed medication.
About the Patient Assistance Program